272 related articles for article (PubMed ID: 16762632)
21. Effect of acute beer ingestion on the liver: studies in female mice.
Kanuri G; Wagnerberger S; Landmann M; Prigl E; Hellerbrand C; Bischoff SC; Bergheim I
Eur J Nutr; 2015 Apr; 54(3):465-74. PubMed ID: 24929790
[TBL] [Abstract][Full Text] [Related]
22. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease.
Pathil A; Mueller J; Warth A; Chamulitrat W; Stremmel W
Hepatology; 2012 May; 55(5):1369-78. PubMed ID: 22183915
[TBL] [Abstract][Full Text] [Related]
23. Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase/acetyl-CoA carboxylase pathway in mice.
Kim D; Lee JE; Jung YJ; Lee AS; Lee S; Park SK; Kim SH; Park BH; Kim W; Kang KP
Int J Mol Med; 2013 Dec; 32(6):1293-302. PubMed ID: 24068196
[TBL] [Abstract][Full Text] [Related]
24. Involvement of RAGE, NADPH oxidase, and Ras/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells.
Sangle GV; Zhao R; Mizuno TM; Shen GX
Endocrinology; 2010 Sep; 151(9):4455-66. PubMed ID: 20630999
[TBL] [Abstract][Full Text] [Related]
25. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
[TBL] [Abstract][Full Text] [Related]
26. Oral intake of chicoric acid reduces acute alcohol-induced hepatic steatosis in mice.
Landmann M; Kanuri G; Spruss A; Stahl C; Bergheim I
Nutrition; 2014; 30(7-8):882-9. PubMed ID: 24985007
[TBL] [Abstract][Full Text] [Related]
27. Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice.
Kanuri G; Landmann M; Priebs J; Spruss A; Löscher M; Ziegenhardt D; Röhl C; Degen C; Bergheim I
Eur J Nutr; 2016 Apr; 55(3):1153-64. PubMed ID: 26003186
[TBL] [Abstract][Full Text] [Related]
28. Metformin prevents endotoxin-induced liver injury after partial hepatectomy.
Bergheim I; Luyendyk JP; Steele C; Russell GK; Guo L; Roth RA; Arteel GE
J Pharmacol Exp Ther; 2006 Mar; 316(3):1053-61. PubMed ID: 16322356
[TBL] [Abstract][Full Text] [Related]
29. Complement C3 contributes to ethanol-induced liver steatosis in mice.
Bykov I; Junnikkala S; Pekna M; Lindros KO; Meri S
Ann Med; 2006; 38(4):280-6. PubMed ID: 16754259
[TBL] [Abstract][Full Text] [Related]
30. IL-1beta mediates induction of hepatic type 1 plasminogen activator inhibitor in response to local tissue injury.
Seki T; Healy AM; Fletcher DS; Noguchi T; Gelehrter TD
Am J Physiol; 1999 Oct; 277(4):G801-9. PubMed ID: 10516146
[TBL] [Abstract][Full Text] [Related]
31. Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin.
Anfosso F; Chomiki N; Alessi MC; Vague P; Juhan-Vague I
J Clin Invest; 1993 May; 91(5):2185-93. PubMed ID: 8387542
[TBL] [Abstract][Full Text] [Related]
32. Hepatocyte growth factor regulates E box-dependent plasminogen activator inhibitor type 1 gene expression in HepG2 liver cells.
Imagawa S; Fujii S; Dong J; Furumoto T; Kaneko T; Zaman T; Satoh Y; Tsutsui H; Sobel BE
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2407-13. PubMed ID: 16902162
[TBL] [Abstract][Full Text] [Related]
33. Metformin prevents hepatic steatosis by regulating the expression of adipose differentiation-related protein.
Liu F; Wang C; Zhang L; Xu Y; Jang L; Gu Y; Cao X; Zhao X; Ye J; Li Q
Int J Mol Med; 2014 Jan; 33(1):51-8. PubMed ID: 24253218
[TBL] [Abstract][Full Text] [Related]
34. The role of fibrinolytic genes and proteins in the development of allograft vascular disease.
Benza RL; Passineau MJ; Anderson PG; Barchue JP; George JF
J Heart Lung Transplant; 2011 Aug; 30(8):935-44. PubMed ID: 21652221
[TBL] [Abstract][Full Text] [Related]
35. Role of Fn14 in acute alcoholic steatohepatitis in mice.
Karaca G; Xie G; Moylan C; Swiderska-Syn M; Guy CD; Krüger L; Machado MV; Choi SS; Michelotti GA; Burkly LC; Diehl AM
Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G325-34. PubMed ID: 25524063
[TBL] [Abstract][Full Text] [Related]
36. Cryptotanshinone from the
Nagappan A; Kim JH; Jung DY; Jung MH
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906014
[TBL] [Abstract][Full Text] [Related]
37. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
Hookman P; Barkin JS
Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
[TBL] [Abstract][Full Text] [Related]
38. Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response.
Spruss A; Henkel J; Kanuri G; Blank D; Püschel GP; Bischoff SC; Bergheim I
Mol Med; 2012 Dec; 18(1):1346-55. PubMed ID: 22952059
[TBL] [Abstract][Full Text] [Related]
39. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
[TBL] [Abstract][Full Text] [Related]
40. Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury.
Horiguchi N; Wang L; Mukhopadhyay P; Park O; Jeong WI; Lafdil F; Osei-Hyiaman D; Moh A; Fu XY; Pacher P; Kunos G; Gao B
Gastroenterology; 2008 Apr; 134(4):1148-58. PubMed ID: 18395093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
